Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC.

Lin, Jessica J

Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 10 2018 - 1530-1538 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1556-1380

10.1016/j.jtho.2018.06.005 doi


Adult
Aged
Carbazoles--pharmacology
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Organophosphorus Compounds--pharmacology
Piperidines--pharmacology
Pyrimidines--pharmacology
Retrospective Studies
Young Adult